160 related articles for article (PubMed ID: 24606323)
1. Individualizing HbA1c targets for patients with diabetes: impact of an automated algorithm within a primary care network.
Berkowitz SA; Atlas SJ; Grant RW; Wexler DJ
Diabet Med; 2014 Jul; 31(7):839-46. PubMed ID: 24606323
[TBL] [Abstract][Full Text] [Related]
2. Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real-life clinical practice.
Alvarez-Guisasola F; Cebrián-Cuenca AM; Cos X; Ruiz-Quintero M; Millaruelo JM; Cahn A; Raz I; Orozco-Beltrán D;
Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29271560
[TBL] [Abstract][Full Text] [Related]
3. Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes.
Magee MF; Baker KM; Fernandez SJ; Huang CC; Mete M; Montero AR; Nassar CM; Sack PA; Smith K; Youssef GA; Evans SR
BMJ Open Diabetes Res Care; 2019; 7(1):e000731. PubMed ID: 31798894
[TBL] [Abstract][Full Text] [Related]
4. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
Rajpathak SN; Rajgopalan S; Engel SS
J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
[TBL] [Abstract][Full Text] [Related]
5. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
6. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.
Mata-Cases M; Mauricio D; Franch-Nadal J
J Diabetes; 2017 Jan; 9(1):34-44. PubMed ID: 26749415
[TBL] [Abstract][Full Text] [Related]
8. Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2010.
Berkowitz SA; Meigs JB; Wexler DJ
Diabetologia; 2013 Dec; 56(12):2593-600. PubMed ID: 23995472
[TBL] [Abstract][Full Text] [Related]
9. Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study.
Critchley JA; Carey IM; Harris T; DeWilde S; Hosking FJ; Cook DG
Diabetes Care; 2018 Oct; 41(10):2127-2135. PubMed ID: 30104296
[TBL] [Abstract][Full Text] [Related]
10. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
11. Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.
Miñambres I; Mediavilla JJ; Sarroca J; Pérez A
BMC Endocr Disord; 2016 Feb; 16():10. PubMed ID: 26887662
[TBL] [Abstract][Full Text] [Related]
12. Assessment of glycemic control among diabetic residents in nursing homes.
Basso A; Peruzzi P; Carollo MC; Improta G; Fedeli U
Diabetes Res Clin Pract; 2012 Jun; 96(3):e80-3. PubMed ID: 22445232
[TBL] [Abstract][Full Text] [Related]
13. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
[TBL] [Abstract][Full Text] [Related]
14. Random blood glucose may be used to assess long-term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting.
Rasmussen JB; Nordin LS; Rasmussen NS; Thomsen JA; Street LA; Bygbjerg IC; Christensen DL
Trop Med Int Health; 2014 Dec; 19(12):1515-9. PubMed ID: 25294180
[TBL] [Abstract][Full Text] [Related]
15. The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study.
McBrien KA; Manns BJ; Hemmelgarn BR; Weaver R; Edwards AL; Ivers N; Rabi D; Lewanczuk R; Braun T; Naugler C; Campbell D; Saad N; Tonelli M
Diabet Med; 2016 Nov; 33(11):1499-1507. PubMed ID: 26526088
[TBL] [Abstract][Full Text] [Related]
16. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
Otieno FC; Ng'ang'a L; Kariuki M
East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes audit.
Hill CJ; Cardwell CR; Patterson CC; Maxwell AP; Magee GM; Young RJ; Matthews B; O'Donoghue DJ; Fogarty DG
Diabet Med; 2014 Apr; 31(4):448-54. PubMed ID: 24102856
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ojo O; Ojo OO; Adebowale F; Wang XH
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
[TBL] [Abstract][Full Text] [Related]
19. Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database.
Aronson R; Orzech N; Ye C; Goldenberg R; Brown V
J Diabetes; 2016 Jan; 8(1):76-85. PubMed ID: 25565383
[TBL] [Abstract][Full Text] [Related]
20. The trials and tribulations of determining HbA
Klein KR; Buse JB
Nat Rev Endocrinol; 2020 Dec; 16(12):717-730. PubMed ID: 33082551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
